Susan Nunez
Pediatric Endocrinology · Austin, TXNPI 1295816817
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $62,897 of the $91,027 with a category attached, or 69.1%. 28 manufacturers reported payments, led by Kyowa Kirin, Inc. at 42.0% of the total. 2025 is the largest year on record at $39,104, 2.8 times the $14,041 reported in 2019. Among pediatric endocrinology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 238 payments — averaging $382.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kyowa Kirin, Inc.$38K
- AbbVie$28K
- Novo Nordisk$10K
- Pfizer$7K
- Eton Pharmaceuticals, Inc.$3K
- Ascendis Pharma Endocrinology Inc$702
- plus $4K from 22 others
What the payments were for
- Consulting fees$5,1446%
- Speaking & faculty fees$62,89769%
- Travel & lodging$13,85415%
- Food & beverage$8,90910%
- Education$2240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kyowa Kirin, Inc. | 67 | $38,246 |
| AbbVie | 33 | $28,151 |
| Novo Nordisk | 21 | $10,305 |
| Pfizer | 9 | $6,966 |
| Eton Pharmaceuticals, Inc. | 4 | $2,952 |
| Ascendis Pharma Endocrinology Inc | 10 | $702 |
| Dexcom, Inc. | 8 | $591 |
| Agios Pharmaceuticals, Inc. | 1 | $555 |
| Tandem Diabetes Care, Inc. | 8 | $429 |
| Medtronic | 7 | $345 |
| Tolmar, Inc. | 22 | $331 |
| Sanofi-aventis U.S. LLC | 3 | $236 |
| Ultragenyx Pharmaceutical Inc. | 9 | $231 |
| BETA Bionics, Inc. | 3 | $193 |
| Insulet Corporation | 11 | $153 |
| Sequel Med Tech, LLC | 6 | $151 |
| Endo USA, Inc. | 1 | $103 |
| Lilly USA, LLC | 2 | $91 |
| Abbott | 2 | $60 |
| Arbor Pharmaceuticals, Inc. | 1 | $39 |
| Teva Pharmaceuticals USA, Inc. | 1 | $37 |
| IBSA Pharma Inc. | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Rhythm Pharmaceuticals, Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Novartis | 1 | $17 |
| Amphastar Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lupron Depot$27,707
- CRYSVITA$17,135
- Norditropin$9,774
- NGENLA$3,997
- GENOTROPIN$2,969
- Alkindi$2,855
- KHINDIVI$1,019
- INCRELEX$1,019
- SKYTROFA$596
- iLet Bionic Pancreas$337
- DEXCOM G6 TRANSMITTER$242
- FENSOLVI$141
- INPEN SMART INSULIN DELIVERY SYSTEM$136
- t:slim X2 Insulin Pump with Control-IQ$134
- Sogroya$127
- iLet Insulin Infusion Kit Inset$112
- iLet Insulin Infusion Kit Contact Detach$112
- SUPPRELIN$103
How this compares
$91,027 in reported general payments places this provider in the 95th percentile of 120 pediatric endocrinology providers in Texas.
Other pediatric endocrinology in Austin
- Shona RabonAustin$8K
- Rajani PrabhakaranAustin$2K
- Amy RydinAustin$1K
- Jose Gamez-GodoyEdinburg$207K
- Virginia AraizaHouston$151K
- Daniel DesalvoHouston$133K
- Amy BurtonPlano$130K
- Hector GranadosEl Paso$73K
- Donnie WilsonFort Worth$58K
- Paul ThorntonFort Worth$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.